This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by An, D. S.
Right arrow Articles by Chen, I. S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by An, D. S.
Right arrow Articles by Chen, I. S. Y.

 Previous Article  |  Next Article 

Journal of Virology, September 1999, p. 7671-7677, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

An Inducible Human Immunodeficiency Virus Type 1 (HIV-1) Vector Which Effectively Suppresses HIV-1 Replication

Dong Sung An, Kouki Morizono, Qi-Xiang Li, Si Hua Mao, Stephanie Lu, and Irvin S. Y. Chen*

Departments of Microbiology & Immunology and Medicine, UCLA School of Medicine, Los Angeles, California 90095

Received 15 January 1999/Accepted 14 June 1999

Recently, gene therapy vectors based upon the human immunodeficiency virus type 1 (HIV-1) genome have been developed. Here, we create an HIV-1 vector which is defective for all HIV-1 genes, but which maintains cis-acting elements required for efficient packaging, infection, and expression. In T cells transduced by this vector, vector expression is low but efficiently induced following HIV-1 infection. Remarkably, although the HIV-1 vector does not contain specific anti-HIV-1 therapeutic genes, the presence of the vector alone is sufficient to inhibit the spread of HIV-1 infection. The mechanism of inhibition is likely to be at the level of competition for limiting substrates required for either efficient packaging or reverse transcription, thereby selecting against propagation of wild-type HIV-1. These results provide proof of a concept for potential application of a novel HIV-1 vector in HIV-1 disease.


* Corresponding author. Mailing address: Departments of Microbiology & Immunology and Medicine, UCLA School of Medicine, Los Angeles, CA 90095-1678. Phone: (310) 825-4793. Fax: (310) 794-7682. E-mail: rtaweesu{at}ucla.edu.


Journal of Virology, September 1999, p. 7671-7677, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Krishnamachary, B., Glunde, K., Wildes, F., Mori, N., Takagi, T., Raman, V., Bhujwalla, Z. M. (2009). Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft. Cancer Res. 69: 3464-3471 [Abstract] [Full Text]  
  • Walsh, C. T., Radeff-Huang, J., Matteo, R., Hsiao, A., Subramaniam, S., Stupack, D., Brown, J. H. (2008). Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61. FASEB J. 22: 4011-4021 [Abstract] [Full Text]  
  • Skasko, M., Kim, B. (2008). Compensatory Role of Human Immunodeficiency Virus Central Polypurine Tract Sequence in Kinetically Disrupted Reverse Transcription. J. Virol. 82: 7716-7720 [Abstract] [Full Text]  
  • Kitayama, H., Miura, Y., Ando, Y., Hoshino, S., Ishizaka, Y., Koyanagi, Y. (2008). Human Immunodeficiency Virus Type 1 Vpr Inhibits Axonal Outgrowth through Induction of Mitochondrial Dysfunction. J. Virol. 82: 2528-2542 [Abstract] [Full Text]  
  • Poon, B., Chang, M. A., Chen, I. S. Y. (2007). Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA. J. Virol. 81: 10515-10523 [Abstract] [Full Text]  
  • Burke, B., Brown, H. J., Marsden, M. D., Bristol, G., Vatakis, D. N., Zack, J. A. (2007). Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus. J. Virol. 81: 7424-7434 [Abstract] [Full Text]  
  • Sander, W. E., Metzger, M. E., Morizono, K., Bonifacino, A., Penzak, S. R., Xie, Y.-M., Chen, I. S.Y., Bacon, J., Sestrich, S. G., Szajek, L. P., Donahue, R. E. (2006). Noninvasive Molecular Imaging to Detect Transgene Expression of Lentiviral Vector in Nonhuman Primates. JNM 47: 1212-1219 [Abstract] [Full Text]  
  • Ardon, O., Zimmerman, E. S., Andersen, J. L., DeHart, J. L., Blackett, J., Planelles, V. (2006). Induction of g2 arrest and binding to cyclophilin a are independent phenotypes of human immunodeficiency virus type 1 vpr.. J. Virol. 80: 3694-3700 [Abstract] [Full Text]  
  • DeHart, J. L., Andersen, J. L., Zimmerman, E. S., Ardon, O., An, D. S., Blackett, J., Kim, B., Planelles, V. (2005). The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration. J. Virol. 79: 1389-1396 [Abstract] [Full Text]  
  • Zimmerman, E. S., Chen, J., Andersen, J. L., Ardon, O., DeHart, J. L., Blackett, J., Choudhary, S. K., Camerini, D., Nghiem, P., Planelles, V. (2004). Human Immunodeficiency Virus Type 1 Vpr-Mediated G2 Arrest Requires Rad17 and Hus1 and Induces Nuclear BRCA1 and {gamma}-H2AX Focus Formation. Mol. Cell. Biol. 24: 9286-9294 [Abstract] [Full Text]  
  • Weinberger, L. S., Schaffer, D. V., Arkin, A. P. (2003). Theoretical Design of a Gene Therapy To Prevent AIDS but Not Human Immunodeficiency Virus Type 1 Infection. J. Virol. 77: 10028-10036 [Abstract] [Full Text]  
  • Roshal, M., Kim, B., Zhu, Y., Nghiem, P., Planelles, V. (2003). Activation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R. J. Biol. Chem. 278: 25879-25886 [Abstract] [Full Text]  
  • STEWART, S. A., DYKXHOORN, D. M., PALLISER, D., MIZUNO, H., YU, E. Y., AN, D. S., SABATINI, D. M., CHEN, I. S.Y., HAHN, W. C., SHARP, P. A., WEINBERG, R. A., NOVINA, C. D. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493-501 [Abstract] [Full Text]  
  • Poon, B., Chen, I. S. Y. (2003). Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA. J. Virol. 77: 3962-3972 [Abstract] [Full Text]  
  • Morizono, K., Bristol, G., Xie, Y.-m., Kung, S. K.-P., Chen, I. S. Y. (2001). Antibody-Directed Targeting of Retroviral Vectors via Cell Surface Antigens. J. Virol. 75: 8016-8020 [Abstract] [Full Text]  
  • An, D. S., Kung, S. K. P., Bonifacino, A., Wersto, R. P., Metzger, M. E., Agricola, B. A., Mao, S. H., Chen, I. S. Y., Donahue, R. E. (2001). Lentivirus Vector-Mediated Hematopoietic Stem Cell Gene Transfer of Common Gamma-Chain Cytokine Receptor in Rhesus Macaques. J. Virol. 75: 3547-3555 [Abstract] [Full Text]  
  • Mautino, M. R., Keiser, N., Morgan, R. A. (2001). Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by HIV-1-Based Lentivirus Vectors Expressing Transdominant Rev. J. Virol. 75: 3590-3599 [Abstract] [Full Text]  
  • Zhu, Y., Gelbard, H. A., Roshal, M., Pursell, S., Jamieson, B. D., Planelles, V. (2001). Comparison of Cell Cycle Arrest, Transactivation, and Apoptosis Induced by the Simian Immunodeficiency Virus SIVagm and Human Immunodeficiency Virus Type 1 vpr Genes. J. Virol. 75: 3791-3801 [Abstract] [Full Text]  
  • Reiser, J., Lai, Z., Zhang, X.-Y., Brady, R. O. (2000). Development of Multigene and Regulated Lentivirus Vectors. J. Virol. 74: 10589-10599 [Abstract] [Full Text]  
  • Kung, S. K. P., An, D. S., Chen, I. S. Y. (2000). A Murine Leukemia Virus (MuLV) Long Terminal Repeat Derived from Rhesus Macaques in the Context of a Lentivirus Vector and MuLV gag Sequence Results in High-Level Gene Expression in Human T Lymphocytes. J. Virol. 74: 3668-3681 [Abstract] [Full Text]  
  • Stewart, S. A., Poon, B., Song, J. Y., Chen, I. S. Y. (2000). Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation. J. Virol. 74: 3105-3111 [Abstract] [Full Text]  
  • An, D. S., Wersto, R. P., Agricola, B. A., Metzger, M. E., Lu, S., Amado, R. G., Chen, I. S. Y., Donahue, R. E. (2000). Marking and Gene Expression by a Lentivirus Vector in Transplanted Human and Nonhuman Primate CD34+ Cells. J. Virol. 74: 1286-1295 [Abstract] [Full Text]